Heron Therapeutics Inc (HRTX)

Cost of Revenue

$45.24M

TTM · Period ending: · USD

HRTX logo

HRTX Cost of Revenue

Latest reported$45.24M
HRTX TTM Cost of Revenue ($0.00 → $45.24M)
High-resolution chart · PNG

HRTX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
632,346
650,912
3,017,592
6,508,512
7,991,885
9,360,000
8,100,000
5,300,000
5,400,000
5,500,000
5,700,000
6,200,000
6,100,000
6,300,000
6,100,000
6,800,000
7,000,000
7,800,000
9,500,000
9,700,000
9,500,000
9,900,000
9,700,000
7,900,000
8,800,000
8,600,000
9,100,000
11,000,000
10,800,000
11,200,000
9,300,000
8,700,000
7,200,000
4,700,000
3,900,000
2,300,000
1,800,000
1,400,000
1,100,000
1,200,000
1,100,000
1,100,000
1,200,000
1,100,000
1,000,000
800,000
500,000
200,000
100,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.